Research toward vaccines against malaria (Q40859526)

24 September 2017

1 reference

title

Research toward vaccines against malaria (English)

1 reference

24 September 2017

0 references

1 reference

1

Miller LH

1 reference

24 September 2017

2

Hoffman SL

1 reference

PubMed ID

9585203

24 September 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

24 September 2017

1 reference

24 September 2017

4

1 reference

24 September 2017

5 Suppl

1 reference

24 September 2017

520-524

1 reference

https://scigraph.springernature.com/pub.10.1038/nm0598supp-520

24 September 2017

0 references

cites work

Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

Pathways and strategies for developing a malaria blood-stage vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

Association of malaria parasite population structure, HLA, and immunological antagonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

Induction of protective immunity against experimental infection with malaria using synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

Efficacy trial of malaria vaccine SPf66 in Gambian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of plasmodium falciparum-infected erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

Non-globular domains in protein sequences: automated segmentation using complexity measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

7 January 2021

Malaria--a neglected disease?

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

7 January 2021

Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

7 January 2021

Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

7 January 2021

Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

7 January 2021

Toward clinical trials of DNA vaccines against malaria

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

7 January 2021

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

7 January 2021

Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

7 January 2021

Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine.

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

7 January 2021

In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

7 January 2021

Identification of two integral membrane proteins of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

7 January 2021

Immunization against blood-stage rodent malaria using purified parasite antigens.

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

7 January 2021

Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

7 January 2021

Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

7 January 2021

Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

7 January 2021

Multiple cross-reactivities amongst antigens of Plasmodium falciparum impair the development of protective immunity against malaria.

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

7 January 2021

Vaccination trials in rhesus monkeys with a minor, invariant, Plasmodium knowlesi 66 kD merozoite antigen.

1 reference

https://api.crossref.org/works/10.1038%2FNM0598SUPP-520

7 January 2021

Identifiers

DOI

10.1038/NM0598SUPP-520

1 reference

24 September 2017

1 reference

PubMed ID

9585203